Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02667444 · ClinicalTrials.gov registry record · Phase 3
P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne
A Phase 3 study, sponsored by Novan.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,330
- Enrollment target
NCT02667444 is a Phase 3 study that has completed, run by Novan. The registered enrollment target is 1,330 participants.
The verdict
NCT02667444, a Phase 3 study, has completed, sponsored by Novan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,330 participants
- Enrollment target
Study Summary
This is a 12 week, multi-center, double-blinded, randomized, vehicle-controlled, parallel group, study to be conducted in approximately 1300 subjects with acne vulgaris in the US.
Interventions
- DRUG Vehicle Gel
- DRUG SB204 4%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,330 participants |
| Start Date | 2016-02-19 |
| Est. Completion | 2016-12-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02667444
The ClinicalTrials.gov registry entry for NCT02667444 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,330 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novan, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle Gel is the first listed.
NCT02667444 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02667444 about?
NCT02667444 is a clinical study titled "P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne". This is a 12 week, multi-center, double-blinded, randomized, vehicle-controlled, parallel group, study to be conducted in approximately 1300 subjects with acne vulgaris in the US.
What is the current status of trial NCT02667444?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,330 participants. The study started on 2016-02-19. Estimated completion is 2016-12-09.
What interventions are being tested in trial NCT02667444?
The interventions under investigation include: Vehicle Gel (DRUG), SB204 4% (DRUG).
Who is sponsoring clinical trial NCT02667444?
This trial is sponsored by Novan, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.